New shot aims to stop aggressive cancers from coming back
NCT ID NCT05726864
Summary
This trial is testing a new immunotherapy called ELI-002 7P. It is for people with pancreatic or colorectal cancer that has a specific genetic change (KRAS or NRAS mutation) and who have already had surgery and chemotherapy. The goal is to see if this treatment can safely help the body's immune system find and destroy any remaining cancer cells to prevent the cancer from returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
City of Hope
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Lehigh Valley Health Network
Allentown, Pennsylvania, 18003, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02210, United States
-
Mayo Clinic Comprehensive Cancer Center
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Comprehensive Cancer Center
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Comprehensive Cancer Center
Rochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10022, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
New York Presbyterian Weill Cornell Medical Center
New York, New York, 10065, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
Ochsner Health
New Orleans, Louisiana, 70121, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of California Los Angeles
Los Angeles, California, 90095, United States
-
University of California, Irvine
Orange, California, 92868, United States
-
University of Colorado Hospital-Anschutz Cancer Pavillion
Aurora, Colorado, 80045, United States
-
University of Florida Health Cancer Center
Gainesville, Florida, 32610, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Miami
Coral Gables, Florida, 33124, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas Southwestern
Dallas, Texas, 75390, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.